TrialPloS one2014

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes.

Ryan R Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.